Article
Prevalence of JAK 2 v617 Mutations in Malignant and Non-Malignant Tumors in the Eastern Province of the Kingdom of Saudi Arabia.
Clinical laboratory - 1 Dec 2024
Alnass Saleh M, Aldosari Sahar, Shaikh Saeed S, Al-Hamad Mohammad A, Al-Ajmi Mariam A, Almarhoon Fatimah A, Almudhry Waheed A, Abu-Saab Amal H A, Almomen Zainab J, Alghanim Mousa A, Almadhary Murtadha H A, Al-Rabea Muneer A, Alnass Rahmah M T
Abstract excerpt
BACKGROUND: Janus kinase II (JAK 2) mutation plays a critical part in the pathophysiology of myeloid pathologies and has been presented to be tangled in thrombotic obstacles of these sicknesses. This study documents the prevalence of JAK 2 v617 mutations in malignant and non-malignant tumors in the Eastern province of the Kingdom of Saudi Arabia. METHODS: A total of 112 patients were included in the current study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.